ClinicalTrials.Veeva

Menu

The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial

I

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Status and phase

Completed
Phase 4

Conditions

ıntrapartum Haemorrhage
Postpartum Haemorrhage

Treatments

Drug: Misoprostol

Study type

Interventional

Funder types

Other

Identifiers

NCT01931410
Aşıcıoğlu-05

Details and patient eligibility

About

The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.

Enrollment

618 patients

Sex

Female

Ages

18 to 44 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. live and singleton pregnancy
  2. Elective caesarean
  3. Gestational week greater than 37 weeks
  4. patient between 18-44 year old

Exclusion criteria

  1. -multiple pregnancy
  2. Preeclampsia
  3. Gestational diabetes
  4. Macrosomia
  5. Oligohidraamnıos
  6. Polihidraamnıos
  7. Myoma
  8. Morbid obesity
  9. Coagulatıon defect (such as HELLP syndrome)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

618 participants in 3 patient groups, including a placebo group

sublingual
Placebo Comparator group
Description:
400 microgram mısoprostol will be administered sublıngually before elective caesarean
Treatment:
Drug: Misoprostol
rectal
Placebo Comparator group
Description:
rectal 600 mgr misoprostol will be administered
Treatment:
Drug: Misoprostol
synpitan
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems